Ekso Bionics Holdings (EKSO) Operating Margin (2016 - 2025)
Historic Operating Margin for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to 33.17%.
- Ekso Bionics Holdings' Operating Margin rose 307500.0% to 33.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 74.9%, marking a year-over-year decrease of 88500.0%. This contributed to the annual value of 58.35% for FY2024, which is 243200.0% up from last year.
- Ekso Bionics Holdings' Operating Margin amounted to 33.17% in Q3 2025, which was up 307500.0% from 193.24% recorded in Q2 2025.
- Ekso Bionics Holdings' Operating Margin's 5-year high stood at 33.17% during Q3 2025, with a 5-year trough of 193.24% in Q2 2025.
- Its 5-year average for Operating Margin is 101.02%, with a median of 97.0% in 2022.
- Its Operating Margin has fluctuated over the past 5 years, first skyrocketed by 1613400bps in 2021, then plummeted by -1460700bps in 2025.
- Ekso Bionics Holdings' Operating Margin (Quarter) stood at 111.68% in 2021, then fell by -12bps to 124.92% in 2022, then soared by 43bps to 71.16% in 2023, then skyrocketed by 38bps to 43.81% in 2024, then rose by 24bps to 33.17% in 2025.
- Its Operating Margin was 33.17% in Q3 2025, compared to 193.24% in Q2 2025 and 101.93% in Q1 2025.